Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ: KPRX · Real-Time Price · USD

1.230

-0.100 (-7.52%)

At close: Nov 13, 2026, 4:00 PM EST

1.250

+0.020 (1.63%)

After-hours: Nov 13, 2026, 4:25 PM EST

Kiora Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1	-	16.02	-	-	-
Revenue Growth	-	-	132746.84%	-	-	-
Cost of Revenue	3.71	3.71	4.9	4.03	3.45	5.35
Gross Profit	-2.71	-3.71	11.12	-4.03	-3.45	-5.35
Selling, General & Admin	6.03	5.75	5.54	4.66	7.28	5.22
Operating Expenses	6.19	5.75	5.54	4.66	7.28	5.22
Operating Income	-8.9	-9.46	5.58	-8.69	-10.73	-10.57
Interest Expense	-0.02	-0.02	-0.02	-0.01	-0.01	-0.01
Interest & Investment Income	0.62	0.89	1.25	0.17	0.06	0
Currency Exchange Gain (Loss)	-0.2	-0.2	-	-	-	-
Other Non Operating Income (Expenses)	0.08	0.04	0.03	0.03	-1.44	-
EBT Excluding Unusual Items	-8.42	-8.75	6.84	-8.5	-12.12	-10.58
Merger & Restructuring Charges	-	-	-	-	-	-0.1
Impairment of Goodwill	-	-	-	-	-	-4.04
Gain (Loss) on Sale of Assets	-	-	-0	-0.03	0	-
Asset Writedown	-	-	-0.1	-	-	-
Other Unusual Items	-0.2	1.25	0.94	-1.99	-1.58	0.75
Pretax Income	-13.25	-12.12	5.66	-12.42	-13.7	-13.96
Income Tax Expense	-0.48	-1.28	2.07	0.09	-0.11	-0.19
Earnings From Continuing Operations	-12.76	-10.84	3.59	-12.51	-13.58	-13.77
Net Income	-12.76	-10.84	3.59	-12.51	-13.58	-13.77
Preferred Dividends & Other Adjustments	-	-	-	0.53	-	-
Net Income to Common	-12.76	-10.84	3.59	-13.04	-13.58	-13.77
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	5	4	4	1	0	0
Shares Outstanding (Diluted)	5	4	4	1	0	0
Shares Change	24.68%	1.01%	666.73%	561.21%	203.73%	110.04%
EPS (Basic)	-2.45	-2.60	0.93	-24.25	-166.94	-514.04
EPS (Diluted)	-2.45	-2.64	0.87	-24.25	-166.94	-514.04
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-7.9	-10.07	8.55	-9.56	-10.43	-10.74
Free Cash Flow Per Share	-1.52	-2.42	2.07	-17.76	-128.16	-400.88
Gross Margin	-271.42%	-	69.43%	-	-	-
Operating Margin	-890.17%	-	34.84%	-	-	-
Profit Margin	-1276.30%	-	22.44%	-	-	-
Free Cash Flow Margin	-789.82%	-	53.39%	-	-	-
EBITDA	-8.86	-9.43	5.6	-8.64	-10.69	-10.53
EBITDA Margin	-	-	34.96%	-	-	-
D&A For EBITDA	0.04	0.02	0.02	0.05	0.04	0.05
EBIT	-8.9	-9.46	5.58	-8.69	-10.73	-10.57
EBIT Margin	-	-	34.84%	-	-	-
Effective Tax Rate	-	-	36.49%	-	-	-
Revenue as Reported	1	-	16.02	-	-	-

SEC Filings: 10-K · 10-Q